The Global Neurodegeneration Proteomics Consortium (GNPC) is a major neurodegenerative disease biomarker discovery effort. Launched in 2023, the GNPC has published four papers in Nature Medicine this week. Three of the four are open access.
The Global Neurodegeneration Proteomics Consortium (GNPC) is a major neurodegenerative disease biomarker discovery effort. Launched in 2023, the GNPC has published four papers in Nature Medicine this week. Three of the four are open access.